Market Overview:
The global GMP biologics market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for monoclonal antibodies and polyclonal antibodies, rising prevalence of chronic diseases, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global GMP biologics market is segmented into monoclonal antibodies and polyclonal antibodies. Monoclonal antibody products are expected to witness higher demand due to their high specificity and affinity towards a particular antigen. Based on application, the global GMP biologics market is segmented into hospitals, clinics, and others (research institutes & contract manufacturing organizations). Hospitals are expected to account for the largest share of this market owing to rising incidence of chronic diseases such as cancer and diabetes mellitus that require treatment with therapeutic proteins & peptides. Geographically, North America dominates the global GMP biologics market followed by Europe due To increasing number of approvals for biosimilars in these regions coupled with presence of major players such as Pfizer Inc., AbbVie Inc., Johnson & Johnson Services Inc.
Product Definition:
GMP Biologics is a term used in the pharmaceutical industry to describe biologic products that are manufactured according to Good Manufacturing Practices (GMP). The purpose of GMP is to ensure that the quality of the biologic product is consistent from batch to batch.
Monoclonal Antibodies:
Monoclonal antibodies are antibody molecules, which are produced by the body's immune system to fight against bacteria, viruses or other harmful substances. The most commonly used monoclonal antibody is called Rituximab manufactured by Roche and approved for treatment of relapsing-remitting multiple sclerosis.
Polyclonal Antibody:
Polyclonal antibodies are made by B cells and are used in the detection of specific antigens. They work by binding to an antigen and so allowing it to stick to a particular protein or cell. In doing so, they enable the immune system of the body to identify and attack any foreign substances that may be present within a person's body.
Application Insights:
The hospitals segment dominated the global GMP biologics market in 2017. This is attributed to factors such as presence of a large number of hospital based diagnostic centers and increasing prevalence of chronic diseases that require regular monitoring and treatment. Furthermore, an increase in the aging population across the globe has resulted in increased demand for targeted drug therapies, which are majorly provided by biologics. These aforementioned factors are expected to drive growth over the forecast period.
GMP biologics find extensive usage across clinics for various applications such as cancer treatment, allergies & immunology, infectious diseases management among others.
Regional Analysis:
North America dominated the global GMP biologics market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate of new technologies are some factors attributing to its large share. In addition, increasing number of R&D activities for the development of novel therapies is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising awareness about biosimilars and growing investment by leading pharmaceutical companies in this region for drug discovery & development activities. Furthermore, favorable regulatory policies regarding biosimilar approval are also expected to contribute towards regional growth over the next eight years. ‘’ denotes confidential information; â‘'¤' denotes missing data Source: Global Market Outlook Report 2018; IMS Health Inc.
Growth Factors:
- Increasing demand for biologics drugs due to rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders.
- Growing investment in R&D by pharmaceutical companies for the development of novel biologic therapies.
- Rising number of approvals for biosimilars by regulatory authorities worldwide.
- Proliferation of contract manufacturing organizations (CMOs) that offer services for the development and manufacture of biologics drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
GMP Biologics Market Research Report
By Type
Monoclonal Antibodies, Polyclonal Antibody
By Application
Hospitals, Clinics, Others
By Companies
Creative Diagnostics, Fisher Bioservices(Thermo Fisher Scientific), Polpharma Biologics, Intertek, HemaCare, AGC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global GMP Biologics Market Report Segments:
The global GMP Biologics market is segmented on the basis of:
Types
Monoclonal Antibodies, Polyclonal Antibody
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Creative Diagnostics
- Fisher Bioservices(Thermo Fisher Scientific)
- Polpharma Biologics
- Intertek
- HemaCare
- AGC
Highlights of The GMP Biologics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal Antibodies
- Polyclonal Antibody
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the GMP Biologics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GMP Biologics is a global biotechnology company that develops and commercializes products for the treatment of serious diseases. The company's products include vaccines, immunotherapies, and other treatments for cancer, infectious diseases, autoimmune disorders, and other conditions. GMP Biologics also provides clinical support services to its customers.
Some of the major companies in the gmp biologics market are Creative Diagnostics, Fisher Bioservices(Thermo Fisher Scientific), Polpharma Biologics, Intertek, HemaCare, AGC.
The gmp biologics market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 GMP Biologics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 GMP Biologics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 GMP Biologics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the GMP Biologics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global GMP Biologics Market Size & Forecast, 2018-2028
4.5.1 GMP Biologics Market Size and Y-o-Y Growth
4.5.2 GMP Biologics Market Absolute $ Opportunity
Chapter 5 Global GMP Biologics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 GMP Biologics Market Size Forecast by Type
5.2.1 Monoclonal Antibodies
5.2.2 Polyclonal Antibody
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global GMP Biologics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 GMP Biologics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global GMP Biologics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 GMP Biologics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America GMP Biologics Analysis and Forecast
9.1 Introduction
9.2 North America GMP Biologics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America GMP Biologics Market Size Forecast by Type
9.6.1 Monoclonal Antibodies
9.6.2 Polyclonal Antibody
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America GMP Biologics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe GMP Biologics Analysis and Forecast
10.1 Introduction
10.2 Europe GMP Biologics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe GMP Biologics Market Size Forecast by Type
10.6.1 Monoclonal Antibodies
10.6.2 Polyclonal Antibody
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe GMP Biologics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific GMP Biologics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific GMP Biologics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific GMP Biologics Market Size Forecast by Type
11.6.1 Monoclonal Antibodies
11.6.2 Polyclonal Antibody
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific GMP Biologics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America GMP Biologics Analysis and Forecast
12.1 Introduction
12.2 Latin America GMP Biologics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America GMP Biologics Market Size Forecast by Type
12.6.1 Monoclonal Antibodies
12.6.2 Polyclonal Antibody
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America GMP Biologics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) GMP Biologics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) GMP Biologics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) GMP Biologics Market Size Forecast by Type
13.6.1 Monoclonal Antibodies
13.6.2 Polyclonal Antibody
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) GMP Biologics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 GMP Biologics Market: Competitive Dashboard
14.2 Global GMP Biologics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Creative Diagnostics
14.3.2 Fisher Bioservices(Thermo Fisher Scientific)
14.3.3 Polpharma Biologics
14.3.4 Intertek
14.3.5 HemaCare
14.3.6 AGC
